Trial Profile
A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients With Advanced Colorectal Cancer and Liver Metastases.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 17 Dec 2007 Status change from in progress to completed.
- 07 Aug 2007 New trial record.